Trafficking of human immunodeficiency virus type 1-specific CD8+ T cells to gut-associated lymphoid tissue during chronic infection. - Wikidata - wikimedia - TriplyDB

Trafficking of human immunodeficiency virus type 1-specific CD8+ T cells to gut-associated lymphoid tissue during chronic infection.

Trafficking of human immunodeficiency virus type 1-specific CD8+ T cells to gut-associated lymphoid tissue during chronic infection.

http://www.wikidata.org/entity/Q34976860

about

CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract Immunity to HIV-1 is influenced by continued natural exposure to exogenous virus.Magnitude and complexity of rectal mucosa HIV-1-specific CD8+ T-cell responses during chronic infection reflect clinical status Targeting Trojan Horse leukocytes for HIV prevention.Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy.Immunogenicity of viral vector, prime-boost SIV vaccine regimens in infant rhesus macaques: attenuated vesicular stomatitis virus (VSV) and modified vaccinia Ankara (MVA) recombinant SIV vaccines compared to live-attenuated SIV.Mucosal T-cell responses to HIV: responding at the front lines Extralymphoid CD8+ T cells resident in tissue from simian immunodeficiency virus SIVmac239{Delta}nef-vaccinated macaques suppress SIVmac239 replication ex vivo.Immunodominant HIV-specific CD8+ T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers.Mucosal immunity in human and simian immunodeficiency lentivirus infections Minimal effect of CD103 expression on the control of a chronic antiviral immune response.The colocalization potential of HIV-specific CD8+ and CD4+ T-cells is mediated by integrin β7 but not CCR6 and regulated by retinoic acid.HIV infection and the gastrointestinal immune system Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection The HIV-1-specific protein Casp8p41 induces death of infected cells through Bax/Bak.Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers.CD14(+) macrophages that accumulate in the colon of African AIDS patients express pro-inflammatory cytokines and are responsive to lipopolysaccharide.Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection.Prolonged tenofovir treatment of macaques infected with K65R reverse transcriptase mutants of SIV results in the development of antiviral immune responses that control virus replication after drug withdrawal.Compared to subcutaneous tenofovir, oral tenofovir disoproxyl fumarate administration preferentially concentrates the drug into gut-associated lymphoid cells in simian immunodeficiency virus-infected macaques.Peripheral and central immune cell reservoirs in tissues from asymptomatic cats chronically infected with feline immunodeficiency virus Getting to the guts of HIV pathogenesis.Early control of highly pathogenic simian immunodeficiency virus/human immunodeficiency virus chimeric virus infections in rhesus monkeys usually results in long-lasting asymptomatic clinical outcomes.Lentiviral vectors encoding human immunodeficiency virus type 1 (HIV-1)-specific T-cell receptor genes efficiently convert peripheral blood CD8 T lymphocytes into cytotoxic T lymphocytes with potent in vitro and in vivo HIV-1-specific inhibitory act Antiviral therapy during primary simian immunodeficiency virus infection fails to prevent acute loss of CD4+ T cells in gut mucosa but enhances their rapid restoration through central memory T cells Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections.A distinct cellular profile is seen in the human endocervix during Chlamydia trachomatis infection.Mucosal immunity to HIV: a review of recent literature.Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control.High frequencies of polyfunctional HIV-specific T cells are associated with preservation of mucosal CD4 T cells in bronchoalveolar lavage.Compartmentalized cytomegalovirus replication and transmission in the setting of maternal HIV-1 infection.A vaccine against CCR5 protects a subset of macaques upon intravaginal challenge with simian immunodeficiency virus SIVmac251.Diminished CD103 (αEβ7) Expression on Resident T Cells from the Female Genital Tract of HIV-Positive Women.Phenotype and functionality of CD4+ and CD8+ T cells in the upper reproductive tract of healthy premenopausal women.Mucosal immunity in HIV controllers: the right place at the right time.Human immunodeficiency virus and the gastrointestinal immune system: does highly active antiretroviral therapy restore gut immunity?Cell-Mediated Immunity in Elite Controllers Naturally Controlling HIV Viral Load.Impact of Immune Deficiency on Remodeling of Maternal Resistance Vasculature 4 Weeks Postpartum in Mice.Immune Activation and HIV-Specific CD8(+) T Cells in Cerebrospinal Fluid of HIV Controllers and Noncontrollers.Longitudinal analysis of distribution and function of plasmacytoid dendritic cells in peripheral blood and gut mucosa of HIV infected patients.

P2860

Q22242965-A9A02DE1-67C6-457D-A231-32CC3D39A246 Q33379075-4D2C550C-5F8F-4D8B-906E-AE8FE50F92F9 Q33381538-04B072E6-1932-4C93-9E23-512EEECD2D7C Q33518390-59F8F82F-43BC-4BBC-9B5D-660A7C5AA1BE Q33611645-BEC3E402-D12C-4DF4-914D-291E5AD7FFF9 Q33653655-F399A536-5E5B-4AD6-B3F2-B44A3837AB4E Q33681946-836EFF55-FF55-4564-80A9-09EC2DA71A28 Q33725546-B024ED9D-40B4-47F5-B317-ECC9294F9E58 Q34120763-528B0480-1B83-4C0E-9723-AD2BE15661E6 Q34131265-95C730EE-3C30-4A9D-B32D-9031D091F832 Q34142360-EEEC4340-5CD7-4B8F-A015-A98199A805E9 Q34217360-DAA8C9F4-5458-4195-8EEA-D9C8BC618099 Q34601874-531F7E26-2A37-4532-BE3C-B31A1CAFFF7E Q35023986-F42D5A4B-FE00-4C3F-8C37-81DC1F3C08AC Q35140447-2E3DD41E-F732-4FFD-828A-95899E927A8E Q35363011-5109A678-E192-4366-A8B0-55FB0D432539 Q35810983-A2F9B052-AA15-4134-AC8F-D6B2B94A86BC Q35857703-73C14957-B99C-42A7-9BF0-B684D9325361 Q36164175-77021B00-50B5-442F-B074-61794A908E40 Q36172455-24E97DAD-0D28-4A02-8DAA-9515347A342C Q36338596-A739C559-56E1-49BF-B3B1-7794D529C784 Q36399719-00C57D28-A7D2-411B-8CCB-A5C8819471D3 Q36473475-A493A584-FF73-403C-8A27-AD353508F666 Q36484055-7228B047-1FD3-450C-93A8-A0E7608F5697 Q36539952-8A51D331-F36B-44BD-84E4-F27A88AF3DFE Q36915902-902BE784-530A-4FFE-942E-DFD40617A37A Q36951927-D9384ADD-A421-4739-AD2F-3E1DC4DD7289 Q37137068-C3FF6DFC-10D3-4D1D-93CF-A1B359D74456 Q37169129-7674A0E9-35B0-4F57-AA9C-EDEAE6275C31 Q37421578-71928896-2B2F-4683-AA01-7DD3D21E9393 Q37528411-DC921075-D6D9-4BF3-A4C6-C821D2FFC9AD Q37547093-F5BECFDA-93F1-4B37-A6D1-7717545FF31E Q37620588-37A5276A-FE7C-410C-9B68-A032E05F084C Q37626039-DA16B53A-11BA-445B-87CD-564977E91EEE Q37852547-EB8C81B1-0BAF-494A-A195-F004F804D1B7 Q38038756-BF533F98-5580-4073-9220-B8BB9A5FBB31 Q38098176-68701B7E-26C5-4567-9E32-A445BB4255BE Q38789230-85F08038-9608-4671-8A0C-78B755025629 Q40739042-85222705-45AA-47F5-BCB4-86E873ED6F01 Q42254144-D94A0CEA-D9A4-4797-8738-37C711C370DF

P2860

Trafficking of human immunodeficiency virus type 1-specific CD8+ T cells to gut-associated lymphoid tissue during chronic infection.

http://www.wikidata.org/entity/Q34976860

description

2003 nî lūn-bûn

@nan

2003 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Trafficking of human immunodef ...... ssue during chronic infection.

@ast

Trafficking of human immunodef ...... ssue during chronic infection.

@en

Trafficking of human immunodef ...... ssue during chronic infection.

@nl

type

label

Trafficking of human immunodef ...... ssue during chronic infection.

@ast

Trafficking of human immunodef ...... ssue during chronic infection.

@en

Trafficking of human immunodef ...... ssue during chronic infection.

@nl

prefLabel

Trafficking of human immunodef ...... ssue during chronic infection.

@ast

Trafficking of human immunodef ...... ssue during chronic infection.

@en

Trafficking of human immunodef ...... ssue during chronic infection.

@nl

P1433

Q34976860-5D25BA0F-8802-4E50-B4C1-C16B6292CAD0

P1476

Q34976860-4CBACFEF-1B8B-4A68-960E-0AAD24FD4E2E

P2093

Q34976860-3E85C933-9F89-415F-A79A-08E4BD1D5701

Q34976860-59B1E7D2-787F-4153-AE41-2FC8909530AF

Q34976860-6A4BED55-9A65-4C6E-B107-A03C96C50EB1

P2860

Q34976860-07CD158C-BF59-4188-82C1-68289F4E77F7

Q34976860-07E755AE-5827-450C-BFF7-2EA7B936B791

Q34976860-0B914715-8C5F-45C3-B42F-E080A9CE474B

Q34976860-0E31BDAD-EE89-40AE-B352-0D1B9E2F2DDB

Q34976860-117766AE-992F-4525-8456-455DE7934227

Q34976860-118D0759-E7D1-4D64-85CB-547C565E7A50

Q34976860-168F6385-74C3-400B-B498-1B23A4EC940B

Q34976860-1A803C0B-4EB5-4C18-AA69-DE6DAE6E2979

Q34976860-2513B02D-8BCA-4ED7-AD05-CDBA62CD1D7C

Q34976860-264F1E28-0950-4128-BD0F-E4977E985156

P304

Q34976860-434B5E37-C4D2-4F59-BFBB-1B7F85789873

P31

Q34976860-CE0F3FB5-3F3E-4D39-BDDA-2BDB53C56394

P356

Q34976860-A0FA37AC-FF8D-44F5-A0DC-19048FE46961

P407

Q34976860-EEE0D987-7390-4990-A4C2-C4B2FE4F6D5B

P433

Q34976860-E3C67181-EFF4-4737-B11F-37F10946402D

P478

Q34976860-E0D0A2C4-4CFB-4C61-8AA4-0C44862F6022

P50

Q34976860-2AFC3E07-A8CC-4E78-8919-95DC49F0B5AB

Q34976860-6D5D3655-567F-465B-A95B-1336DE20D464

Q34976860-ADEE97A9-CBB0-45E5-97F5-C5176BFC2186

P577

Q34976860-5172C0A7-2585-49B4-9260-C2E72C436FF7

P5875

Q34976860-44900984-A702-48AD-A04E-731310A818BF

P698

Q34976860-0DE4673E-9EC1-4D1E-8F3E-4267799E9585

P932

Q34976860-F59C3318-D3C3-45B8-B5F6-2A7FF3FFF798

P356

JVI.77.10.5621-5631.2003

P1433

Journal of Virology

P1476

Trafficking of human immunodef ...... ssue during chronic infection.

@en

P2093

Catherine A Cox

http://www.w3.org/2001/XMLSchema#string

Mark A Jacobson

http://www.w3.org/2001/XMLSchema#string

Neil H Stollman

http://www.w3.org/2001/XMLSchema#string

P2860

Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis

Human intestinal lamina propria and intraepithelial lymphocytes express receptors specific for chemokines induced by inflammation

Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity

The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune system

Regulated production of interferon-inducible T-cell chemoattractants by human intestinal epithelial cells

T-Cell Function and Migration — Two Sides of the Same Coin

Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection

Rapid acquisition of tissue-specific homing phenotypes by CD4(+) T cells activated in cutaneous or mucosal lymphoid tissues

Cytomegalovirus infection in patients with HIV infection.

Putative immunodominant human immunodeficiency virus-specific CD8(+) T-cell responses cannot be predicted by major histocompatibility complex class I haplotype

P304

5621-5631

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.77.10.5621-5631.2003

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

77

http://www.w3.org/2001/XMLSchema#string

P50

Johan K Sandberg

Douglas F. Nixon

Barbara L Shacklett

P577

2003-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7385444

http://www.w3.org/2001/XMLSchema#string

P698

12719554

http://www.w3.org/2001/XMLSchema#string

P932

154016

http://www.w3.org/2001/XMLSchema#string